Skip to content
healthcare.dev

Losartan Potassium and Hydrochlorothiazide

NDC 68180-215, Losartan Potassium and Hydrochlorothiazide, tablet, from Lupin Pharmaceuticals, Inc..

Product NDC
68180-215
Status
Listed
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078245
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68180-215 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROCHLOROTHIAZIDE12.5 mg/1
  • LOSARTAN POTASSIUM50 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
68180-215-066818002150630 TABLET in 1 BOTTLE (68180-215-06)
68180-215-096818002150990 TABLET in 1 BOTTLE (68180-215-09)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ee1eaaf6-050b-48af-942b-5e3451edc164
  • NADAC price for package 68180021506

    GET /v1/drugs/nadac/68180021506
  • NADAC price for package 68180021509

    GET /v1/drugs/nadac/68180021509

Use it

Look up 68180-215 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68180-215 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68180-215. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.